Tasly Biopharma’s Advanced Malignant Solid Tumors of Digestive Tract Drug T601 Successfully Completes the First Subject Administration of Phase I/IIa Clinical Trial

Tasly Biopharma’s Advanced Malignant Solid Tumors of Digestive Tract Drug T601 Successfully Completes the First Subject Administration of Phase I/IIa Clinical Trial